Scientific Review of Phase I Protocols With Novel Dose-Escalation Designs: How Much Information Is Needed? Academic Article uri icon

Overview

publication date

  • May 4, 2015

Research

keywords

  • Antineoplastic Agents
  • Clinical Trials, Phase I as Topic
  • Maximum Tolerated Dose
  • Medical Oncology
  • Research Design

Identity

PubMed Central ID

  • PMC4962621

Scopus Document Identifier

  • 84937133576

Digital Object Identifier (DOI)

  • 10.1200/JCO.2014.59.8466

PubMed ID

  • 25940721

Additional Document Info

volume

  • 33

issue

  • 19